Skip to content

Author

J. Jouniaux

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

30 Myeloid- Versus Effector-Driven Circulating Immune States Define Treatment-Specific Benefit in Metastatic Clear Cell Renal Cell Carcinoma

Abstract Background Metastatic clear cell renal cell carcinoma (ccRCC) first-line treatment relies on immune checkpoint inhibitor (ICI)-based regimens, including either dual ICI or ICI plus antiangiogenic tyrosine kinase inhibitor (TKI). Despite substantial clinical progress, predictive biomarkers guiding regimen selec...

M. Calabrese, N. Chaput, Marine Aglave et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.